| APOBEC3A catalyzes mutation and drives carcinogenesis in vivo EK Law, R Levin-Klein, MC Jarvis, H Kim, PP Argyris, MA Carpenter, ... Journal of Experimental Medicine 217 (12), 2020 | 113 | 2020 |
| Structure and dynamics of SARS-CoV-2 proofreading exoribonuclease ExoN NH Moeller, K Shi, Ö Demir, C Belica, S Banerjee, L Yin, C Durfee, ... Proceedings of the National Academy of Sciences 119 (9), e2106379119, 2022 | 109 | 2022 |
| An immunogenic model of KRAS-mutant lung cancer enables evaluation of targeted therapy and immunotherapy combinations J Boumelha, S de Carné Trécesson, EK Law, P Romero-Clavijo, ... Cancer research 82 (19), 3435-3448, 2022 | 30 | 2022 |
| The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance DR Caswell, P Gui, MK Mayekar, EK Law, O Pich, C Bailey, J Boumelha, ... Nature Genetics 56 (1), 60-73, 2024 | 10 | 2024 |
| Human APOBEC3B promotes tumor development in vivo including signature mutations and metastases C Durfee, NA Temiz, R Levin-Klein, PP Argyris, L Alsøe, S Carracedo, ... Cell Reports Medicine 4 (10), 2023 | 8 | 2023 |
| DNA deamination is required for human APOBEC3A-driven hepatocellular carcinoma in vivo JA Naumann, PP Argyris, MA Carpenter, HB Gupta, Y Chen, NA Temiz, ... International journal of molecular sciences 24 (11), 9305, 2023 | 6 | 2023 |
| TP53/p53 facilitates stress-induced exosome and protein secretion by adipocytes Y Huang, AV Hertzel, SR Fish, CL Halley, EK Bohm, HM Martinez, ... Diabetes 72 (11), 1560-1573, 2023 | 4 | 2023 |
| Human APOBEC3B promotes tumor heterogeneity in vivo including signature mutations and metastases C Durfee, NA Temiz, R Levin-Klein, PP Argyris, L Alsøe, S Carracedo, ... BioRxiv, 2023 | 4 | 2023 |
| Mesoscale DNA features impact APOBEC3A and APOBEC3B deaminase activity and shape tumor mutational landscapes A Sanchez, P Ortega, R Sakhtemani, L Manjunath, S Oh, E Bournique, ... Nature communications 15 (1), 2370, 2024 | 3 | 2024 |
